로딩 중…
지수 로딩 중…
Ionis Pharmaceuticals, Inc.
IONS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$74.12-0.26%
2026-06-18
Price Chart
Ionis Pharmaceuticals, Inc.+100.27%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $12.25B |
| Revenue | $1.06B |
| Net Income | $-327M |
| Total Assets | $3.45B |
| Net Assets | $491M |
| Value | |
| P/B | 24.93x |
| P/S | 11.58x |
| EV/EBITDA | 3.11x |
| FCF Yield | -7.93% |
| Profitability | |
| ROE | -66.46% |
| ROA | -9.47% |
| Op. Margin | -33.35% |
| Revenue Growth | 86.98% |
| Financial Health | |
| Debt Ratio | 602.05% |
| Total Debt | $2.04B |
| FCF | $-971M |
| Cash | $173M |
| Current Ratio | 4.10x |
| Net Debt/EBITDA | 0.41x |
| Performance | |
| 1Y Return | 100.27% |
| 1M Return | 0.38% |
| From 52W High | -14.55% |
| 1Y MDD | -19.45% |
| Trading | |
| Volume | 2,384,442 shares |
| Trading Value | $177M |
| Per Share | |
| EPS | $-2.35 |
| BPS | $3.02 |